Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Fulgent Genetics Inc (FLGT)

Fulgent Genetics Inc (FLGT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 377,979
  • Shares Outstanding, K 21,698
  • Annual Sales, $ 32,530 K
  • Annual Income, $ -410 K
  • 60-Month Beta 1.70
  • Price/Sales 10.71
  • Price/Cash Flow 114.60
  • Price/Book 4.28

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/20
See More
  • Average Estimate -0.03
  • Number of Estimates 1
  • High Estimate -0.03
  • Low Estimate -0.03
  • Prior Year 0.02
  • Growth Rate Est. (year over year) -250.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
12.36 +40.94%
on 05/05/20
20.30 -14.19%
on 05/18/20
+0.13 (+0.75%)
since 04/29/20
3-Month
6.70 +160.00%
on 03/16/20
20.30 -14.19%
on 05/18/20
+2.58 (+17.39%)
since 02/28/20
52-Week
5.25 +231.81%
on 06/19/19
20.60 -15.44%
on 02/19/20
+11.44 (+191.30%)
since 05/29/19

Most Recent Stories

More News
Fulgent Genetics Receives Emergency Use Authorization from the FDA for its RT-PCR Test for Detection of SARS-CoV-2, the Virus that Causes COVID-19

Fulgent Genetics, Inc. (NASDAQ: FLGT) ("Fulgent Genetics" or the "company"), a provider of comprehensive genetic testing solutions, today announced that its subsidiary, Fulgent Therapeutics, LLC, has received...

FLGT : 17.42 (+8.47%)
FULGENT GENETIC (FLGT) Reports Q1 Loss, Tops Revenue Estimates

FULGENT GENETIC (FLGT) delivered earnings and revenue surprises of 0.00% and 0.82%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

FLGT : 17.42 (+8.47%)
Fulgent Genetics Reports First Quarter 2020 Financial Results

First Quarter 2020 Results:

FLGT : 17.42 (+8.47%)
Will FULGENT GENETIC (FLGT) Report Negative Earnings Next Week? What You Should Know

FULGENT GENETIC (FLGT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

FLGT : 17.42 (+8.47%)
Fulgent Genetics to Announce First Quarter 2020 Financial Results on Monday May 4, 2020

Fulgent Genetics, Inc. (NASDAQ: FLGT) ("Fulgent Genetics" or the "company") today announced that it will release its first quarter 2020 financial results after the market closes on Monday May 4, 2020....

FLGT : 17.42 (+8.47%)
Fulgent Genetics Provides Update on Testing for COVID-19

Fulgent Genetics, Inc. (NASDAQ: FLGT) ("Fulgent Genetics" or the "company"), a provider of comprehensive genetic testing and Next Generation Sequencing ("NGS") solutions, today announced that it is offering...

FLGT : 17.42 (+8.47%)
Fulgent Genetics Announces Launch of Next Generation Sequencing (NGS) Test to Detect Coronavirus Disease (COVID-19)

Fulgent Genetics, Inc. (NASDAQ: FLGT) ("Fulgent Genetics" or the "company"), a provider of comprehensive genetic testing and Next Generation Sequencing ("NGS") solutions, today announced the launch of...

FLGT : 17.42 (+8.47%)
Fulgent Genetics Reports Fourth Quarter and Full Year 2019 Financial Results

Fourth Quarter 2019 Results:

FLGT : 17.42 (+8.47%)
Fulgent Genetics, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / March 10, 2020 / Fulgent Genetics, Inc. (NASDAQ:FLGT) will be discussing their earnings results in their 2019 Fourth Quarter Earnings call to be held on March 10, 2020 at 4:30...

FLGT : 17.42 (+8.47%)
Fulgent Genetics Announces Promotion of Brandon Perthuis to Chief Commercial Officer

Fulgent Genetics, Inc. (NASDAQ: FLGT) ("Fulgent Genetics" or the "company"), a provider of comprehensive genetic testing and Next Generation Sequencing ("NGS") solutions, today announced the promotion...

FLGT : 17.42 (+8.47%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade FLGT with:

Business Summary

Fulgent Genetics, Inc. is a technology company. It provide genetic testing services to physicians with clinically actionable diagnostic information. The Company's technology platform integrates data comparison and suppression algorithms, adaptive learning software, advanced genetic diagnostics tools...

See More

Key Turning Points

2nd Resistance Point 18.97
1st Resistance Point 18.20
Last Price 17.42
1st Support Level 16.45
2nd Support Level 15.48

See More

52-Week High 20.60
Last Price 17.42
Fibonacci 61.8% 14.74
Fibonacci 50% 12.93
Fibonacci 38.2% 11.11
52-Week Low 5.25

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar